https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Osimertinib With Chemotherapy Improves OS in Patients With EGFRm NSCLC

Osimertinib With Chemotherapy Improves OS in Patients With EGFRm NSCLC

The combination regimen had stronger benefits in patients with locally advanced or metastatic epidermal growth receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC) than osimertinib alone.

administrator

Related Articles